Ras/Raf/MEK/ERK pathway has been detected continuously active in HCC following the interaction with epidermal growth factor receptor (EGFR), tyrosine-protein kinase Met (c-Met), and FGFRs [98]. The gene discussed is MET; the disease is hepatocellular carcinoma.